1. Home
  2. SLGL vs FTF Comparison

SLGL vs FTF Comparison

Compare SLGL & FTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

N/A

Current Price

$73.50

Market Cap

247.1M

Sector

Health Care

ML Signal

N/A

Logo Franklin Limited Duration Income Trust of Beneficial Interest

FTF

Franklin Limited Duration Income Trust of Beneficial Interest

HOLD

Current Price

$5.77

Market Cap

233.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLGL
FTF
Founded
1997
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
247.1M
233.9M
IPO Year
2016
2003

Fundamental Metrics

Financial Performance
Metric
SLGL
FTF
Price
$73.50
$5.77
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$110.00
N/A
AVG Volume (30 Days)
28.4K
271.2K
Earning Date
05-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$223.84
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.96
$5.70
52 Week High
$97.97
$6.54

Technical Indicators

Market Signals
Indicator
SLGL
FTF
Relative Strength Index (RSI) 51.77 42.22
Support Level $66.85 $5.72
Resistance Level $75.00 $5.85
Average True Range (ATR) 5.47 0.04
MACD -0.11 -0.00
Stochastic Oscillator 42.45 36.28

Price Performance

Historical Comparison
SLGL
FTF

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About FTF Franklin Limited Duration Income Trust of Beneficial Interest

Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective, is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.

Share on Social Networks: